530313 — Kimia Biosciences Income Statement
0.000.00%
Last trade - 00:00- IN₹1.82bn
- IN₹2.20bn
- IN₹1.05bn
- 67
- 35
- 38
- 44
Annual income statement for Kimia Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,063 | 1,327 | 1,249 | 1,285 | 1,049 |
| Cost of Revenue | |||||
| Gross Profit | 260 | 359 | 326 | 241 | 239 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,035 | 1,262 | 1,272 | 1,364 | 1,083 |
| Operating Profit | 28.1 | 64.7 | -23.1 | -79 | -33.8 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 12.3 | 55.3 | -50.2 | -124 | -71.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 13.8 | 51 | -37 | -93.5 | -53.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 13.8 | 51 | -37 | -93.5 | -53.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 13.8 | 51 | -37 | -93.5 | -53.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.294 | 1.07 | -0.794 | -1.83 | -1.12 |